Phase 1 Trial of ABT-888 and SCH727965 in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 29 May 2017
At a glance
- Drugs Carboplatin (Primary) ; Dinaciclib (Primary) ; Veliparib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 28 Jan 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
- 03 Nov 2015 According to ClinicalTrials.gov record, the treatment table has been amended.
- 03 Nov 2015 Planned number of patients changed from 116 to 130, according to ClinicalTrials.gov record.